Search Results - "Kidoguchi, Satoshi"

Refine Results
  1. 1
  2. 2

    Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats by Ogura, Takahiro, Kitada, Kento, Morisawa, Norihiko, Fujisawa, Yoshihide, Kidoguchi, Satoshi, Nakano, Daisuke, Kobara, Hideki, Masaki, Tsutomu, Titze, Jens, Nishiyama, Akira

    Published in Hypertension research (01-01-2023)
    “…We recently reported that skin vasoconstriction to suppress transepidermal water loss (TEWL) leads to hypertension in renal injury model rats with impaired…”
    Get full text
    Journal Article
  3. 3

    Bilateral or Unilateral Aldosterone Hypersecretion and Responsiveness to Therapy Are Associated with Differences in Calcium/Phosphate Homeostasis in Patients with Primary Aldosteronism by Yarita-Kawana, Miki, Kidoguchi, Satoshi, Suehiro, Yohei, Sugano, Naoki, Yokoo, Takashi

    Published in Internal Medicine (01-10-2024)
    “…Introduction Primary aldosteronism is characterized by the autonomous excretion of aldosterone, which may induce bone mineral disorders. Methods A total of 96…”
    Get full text
    Journal Article
  4. 4

    Antihypertensive Drugs and Cancer Risk by Kidoguchi, Satoshi, Sugano, Naoki, Yokoo, Takashi, Kaneko, Hidehiro, Akazawa, Hiroshi, Mukai, Mikio, Node, Koichi, Yano, Yuichiro, Nishiyama, Akira

    Published in American journal of hypertension (01-09-2022)
    “…Abstract Hypertension is the most prevalent comorbidity in cancer patients. Consequently, many cancer patients are prescribed antihypertensive drugs before…”
    Get full text
    Journal Article
  5. 5

    Sodium/glucose cotransporter 2 and renoprotection: From the perspective of energy regulation and water conservation by Kitada, Kento, Kidoguchi, Satoshi, Nakano, Daisuke, Nishiyama, Akira

    Published in Journal of pharmacological sciences (01-11-2021)
    “…Sodium/glucose cotransporter 2 (SGLT2) is a renal low-affinity high-capacity sodium/glucose cotransporter expressed in the apical membrane of the early segment…”
    Get full text
    Journal Article
  6. 6

    Tolvaptan induces body fluid loss and subsequent water conservation in normal rats by Kidoguchi, Satoshi, Kitada, Kento, Fujisawa, Yoshihide, Nakano, Daisuke, Yokoo, Takashi, Titze, Jens, Nishiyama, Akira

    Published in Journal of pharmacological sciences (01-07-2022)
    “…We have recently reported that the urea osmolyte-associated water conservation system is activated in fluid loss models such as high salt-induced natriuresis,…”
    Get full text
    Journal Article
  7. 7

    Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study by Sugano, Naoki, Maruyama, Yukio, Kidoguchi, Satoshi, Ohno, Iwao, Wada, Atsushi, Shigematsu, Takashi, Masakane, Ikuto, Yokoo, Takashi

    Published in PloS one (06-06-2019)
    “…Whether higher serum uric acid (UA) values comprise a risk factor for death and whether treatment for high UA is effective in patients undergoing hemodialysis…”
    Get full text
    Journal Article
  8. 8

    Azilsartan causes natriuresis due to its sympatholytic action in kidney disease by Kidoguchi, Satoshi, Sugano, Naoki, Takane, Koki, Takahashi, Yasuhito, Morisawa, Norihiko, Yarita, Miki, Hayashi-Ishikawa, Naomi, Tokudome, Goro, Yokoo, Takashi

    Published in Hypertension research (01-10-2019)
    “…The sympathoinhibitory mechanism of azilsartan was investigated in an adenine-induced chronic renal failure model. Azilsartan exerted an antihypertensive…”
    Get full text
    Journal Article
  9. 9

    The characteristics of captopril challenge test–positive patients using various criteria by Kidoguchi, Satoshi, Sugano, Naoki, Hayashi-Ishikawa, Naomi, Morisawa, Norihiko, Tokudome, Goro, Yokoo, Takashi

    “…Introduction: The captopril challenge test (CCT) is the major confirmatory test for primary aldosteronism (PA), and frequently carried out because of its…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Serum uric acid and the incidence of CKD and hypertension by Kuriyama, Satoru, Maruyama, Yukio, Nishio, Shinichiro, Takahashi, Yasuhito, Kidoguchi, Satoshi, Kobayashi, Chisa, Takahashi, Daisuke, Sugano, Naoki, Hosoya, Tatsuo, Yokoo, Takashi

    Published in Clinical and experimental nephrology (01-12-2015)
    “…Background Uric acid (UA) levels correlate positively with the prevalence of chronic kidney disease (CKD) and/or hypertension. We tested the hypothesis that UA…”
    Get full text
    Journal Article
  12. 12

    Evaluation of various confirmatory tests for the diagnosis of aldosterone-producing adenoma by Kidoguchi, Satoshi, Sugano, Naoki, Kawauchi, Ruri, Nakashima, Daisuke, Hayashi-Ishikawa, Naomi, Tokudome, Goro, Yokoo, Takashi

    “…Introduction: Adrenal venous sampling is useful for discriminating unilateral and bilateral hypersecretion in patients with primary aldosteronism, but it is…”
    Get full text
    Journal Article
  13. 13

    S-45-1: ONCO-HYPERTENSION: CONCEPT AND FUTURE PERSPECTIVES by Kidoguchi, Satoshi

    Published in Journal of hypertension (01-01-2023)
    “…In these decades, the morbidity of cancer has been increasing worldwide. On the other hand, the development of cancer treatment, such as small-molecule…”
    Get full text
    Journal Article
  14. 14

    Successful treatment of BK virus nephropathy using therapeutic drug monitoring of mycophenolic acid by Kobayashi, Akimitsu, Yamamoto, Izumi, Nakada, Yasuyuki, Kidoguchi, Satoshi, Matsuo, Nanae, Tanno, Yudo, Ohkido, Ichiro, Tsuboi, Nobuo, Yamamoto, Hiroyasu, Yokoyama, Keitaro, Yokoo, Takashi

    Published in Nephrology (Carlton, Vic.) (01-06-2014)
    “…We report the successful management of BK virus nephropathy (BKVN) using therapeutic drug monitoring (TDM) of mycophenolic acid (MPA). A 40‐year‐old woman was…”
    Get full text
    Journal Article
  15. 15

    SODIUM RESTRICTION CONCOMITANT WITH SUFFICIENT ALDOSTERONE SUPPRESSION MAY BE ASSOCIATED WITH RENOPROTECTIVE EFFECTS IN THE PATIENTS WITH PRIMARY ALDOSTERONISM by Kidoguchi, Satoshi, Sugano, Naoki, Yokoo, Takashi

    Published in Journal of hypertension (01-05-2024)
    “…Objective: Primary aldosteronism (PA) is an independent risk factor for various cardiovascular diseases and chronic kidney disease, which makes it important to…”
    Get full text
    Journal Article
  16. 16

    DOES ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR EXACERBATE RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE? by Suehiro, Yohei, Sugano, Naoki, Kidoguchi, Satoshi, Yokoo, Takashi

    Published in Journal of hypertension (01-05-2024)
    “…Objective: Angiotensin receptor neprilysin inhibitor (ARNI) is a new drug with potent antihypertensive effect and has been reported to exert cardiovascular…”
    Get full text
    Journal Article
  17. 17

    PS-B08-5: EFFECT OF HIGH SALT INTAKE ON THE SODIUM CONTENT OF EACH BONE IN RATS by Munesada, Mahiro, Kitada, Kento, Kidoguchi, Satoshi, Nakano, Daisuke, Nishiyama, Akira

    Published in Journal of hypertension (01-01-2023)
    “…Objective: It has been reported that salt intake affects sodium content at the tissue level. Salt intake alters bone sodium content, which shifts the balance…”
    Get full text
    Journal Article
  18. 18

    New Concept of Onco-Hypertension and Future Perspectives by Kidoguchi, Satoshi, Sugano, Naoki, Tokudome, Gorou, Yokoo, Takashi, Yano, Yuichiro, Hatake, Kiyohiko, Nishiyama, Akira

    Published in Hypertension (Dallas, Tex. 1979) (01-01-2021)
    “…Owing to aging populations, the prevalence of hypertension and associated cardiovascular events has been increasing worldwide. The morbidity and mortality due…”
    Get full text
    Journal Article
  19. 19

    Abstract 23: Body Fluid And Sodium Loss Leads To Aldosterone Hypersecretion And Muscle Catabolism In Hepatocellular Carcinoma Rats by Kidoguchi, Satoshi, Kitada, Kento, Nakano, Daisuke, Yokoo, Takashi, Nishiyama, Akira

    Published in Hypertension (Dallas, Tex. 1979) (01-09-2021)
    “…BackgroundThe number of cancer survivors coincides with cardiovascular diseases is increasing, therefore, we are promoting the concept of “Onco-Hypertension”…”
    Get full text
    Journal Article
  20. 20

    THE CHARACTERISTICS OF PATIENTS SENSITIVE TO MINERALOCORTICOID RECEPTOR ANTAGONISTS by Kidoguchi, Satoshi, Sugano, Naoki, Takahashi, Daisuke, Yokoo, Takashi

    Published in Journal of hypertension (01-04-2021)
    “…Objective: Primary aldosteronism (PA) is related to various cardiovascular events, thus the treatment of this disease is exceedingly important. From the…”
    Get full text
    Journal Article